As of 2025-09-15, the Relative Valuation of Novavax Inc (NVAX) is 42.69 USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.98 USD, the upside of Novavax Inc based on Relative Valuation is 435.0%.
The range of the Relative Valuation is 35.14 - 49.57 USD.
| Range | Selected | |
| Trailing P/E multiples | 14.8x - 17.7x | 16.6x |
| Forward P/E multiples | 13.5x - 19.0x | 16.2x |
| Fair Price | 35.14 - 49.57 | 42.69 |
| Upside | 340.4% - 521.1% | 435.0% |
| Date | P/E |
| 2025-09-12 | 3.07 |
| 2025-09-11 | 3.18 |
| 2025-09-10 | 3.06 |
| 2025-09-09 | 3.06 |
| 2025-09-08 | 2.97 |
| 2025-09-05 | 3.03 |
| 2025-09-04 | 2.99 |
| 2025-09-03 | 2.84 |
| 2025-09-02 | 2.90 |
| 2025-08-29 | 2.87 |
| 2025-08-28 | 2.91 |
| 2025-08-27 | 2.91 |
| 2025-08-26 | 2.88 |
| 2025-08-25 | 2.89 |
| 2025-08-22 | 3.01 |
| 2025-08-21 | 2.93 |
| 2025-08-20 | 3.36 |
| 2025-08-19 | 3.66 |
| 2025-08-18 | 3.73 |
| 2025-08-15 | 3.68 |
| 2025-08-14 | 3.62 |
| 2025-08-13 | 3.40 |
| 2025-08-12 | 3.26 |
| 2025-08-11 | 3.08 |
| 2025-08-08 | 3.22 |
| 2025-08-07 | 3.37 |
| 2025-08-06 | 2.91 |
| 2025-08-05 | 2.59 |
| 2025-08-04 | 2.59 |
| 2025-08-01 | 2.52 |
| 2025-07-31 | 2.55 |
| 2025-07-30 | 2.63 |
| 2025-07-29 | 2.69 |
| 2025-07-28 | 2.80 |
| 2025-07-25 | 2.87 |
| 2025-07-24 | 2.93 |
| 2025-07-23 | 3.01 |
| 2025-07-22 | 2.77 |
| 2025-07-21 | 2.75 |
| 2025-07-18 | 2.69 |
| 2025-07-17 | 2.69 |
| 2025-07-16 | 2.67 |
| 2025-07-15 | 2.64 |
| 2025-07-14 | 2.68 |
| 2025-07-11 | 2.63 |
| 2025-07-10 | 2.73 |
| 2025-07-09 | 2.70 |
| 2025-07-08 | 2.70 |
| 2025-07-07 | 2.54 |
| 2025-07-03 | 2.61 |